#BEGIN_DRUGCARD DB03763

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H14N2O5

# Chemical_IUPAC_Name:
5-[(2R,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
5-Methyl-2'-Deoxypseudouridine

# HET_ID:
5MD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H14N2O5/c1-12-3-5(9(15)11-10(12)16)7-2-6(14)8(4-13)17-7/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7-,8+/m1/s1

# InChI_Key:
InChIKey=AMDJRICBYOAHBZ-PRJMDXOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3763

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
242.2286

# Molecular_Weight_Mono:
242.090271568

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1F8Y

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-0.55

# Predicted_Water_Solubility:
6.80e+01 g/l

# Primary_Accession_No:
DB03763

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936788

# PubChem_Substance_ID:
46505970

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00252

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CN1C=C([C@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ntd

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
7797550	Porter DJ, Merrill BM, Short SA: Identification of the active site nucleophile in nucleoside 2-deoxyribosyltransferase as glutamic acid 98. J Biol Chem. 1995 Jun 30;270(26):15551-6.
8805514	Armstrong SR, Cook WJ, Short SA, Ealick SE: Crystal structures of nucleoside 2-deoxyribosyltransferase in native and ligand-bound forms reveal architecture of the active site. Structure. 1996 Jan 15;4(1):97-107.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3050

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
18081

# Drug_Target_1_Name:
Nucleoside deoxyribosyltransferase

# Drug_Target_1_Number_of_Residues:
157

# Drug_Target_1_PDB_ID:
1F8Y

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF05014	Nuc_deoxyrib_tr

# Drug_Target_1_Protein_Sequence:
>Nucleoside deoxyribosyltransferase
MPKKTIYFGAGWFTDRQNKAYKEAMEALKENPTIDLENSYVPLDNQYKGIRVDEHPEYLH
DKVWATATYNNDLNGIKTNDIMLGVYIPDEEDVGLGMELGYALSQGKYVLLVIPDEDYGK
PINLMSWGVSDNVIKMSQLKDFNFNKPRFDFYEGAVY

# Drug_Target_1_Reaction:
2-deoxy-D-ribosyl-base1 + base2 = 2-deoxy-D-ribosyl-base2 + base1

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the cleavage of the glycosidic bond of 2'- deoxyribonucleosides and the transfer of the deoxyribosyl moiety to an acceptor purine or pyrimidine base

# Drug_Target_1_SwissProt_ID:
Q9R5V5

# Drug_Target_1_SwissProt_Name:
NTD_LACLE

# Drug_Target_1_Synonyms:
EC 2.4.2.6
N- deoxyribosyltransferase

# Drug_Target_1_Theoretical_pI:
4.41

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03763
